In re: Request from South Korea
| Regeneron Pharmaceuticals, Inc. |
| Biogen Inc. |
| 1:2023cv01124 |
| October 10, 2023 |
| US District Court for the District of Delaware |
| Laura D Hatcher |
| Maryellen Noreika |
| Other Statutory Actions |
| 28 U.S.C. ยง 1782 Letter rogatory - appointment |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 14, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 AFFIDAVIT of Service for Ex Parte Application for an Order Pursuant to 28 U.S.C. Section 1782 to take Discovery for use in Foreign Proceedings with supporting exhibits, and Order Authorizing Discovery under 28 U.S.C. Section 1782 served on Biogen Inc. on November 13, 2023, filed by Regeneron Pharmaceuticals, Inc.. (Wilks, David) |
Filing 11
ORDER re #1 Granting the Application for Issuance of Discovery filed by Regeneron Pharmaceuticals, Inc.. Signed by Judge Laura D. Hatcher on 11/13/23. (kjk)
|
| Filing 10 NOTICE OF SERVICE of Applicant Regeneron Pharmaceuticals, Inc. Motion for an Expedited Teleconference to Resolve Discovery Dispute filed by Regeneron Pharmaceuticals, Inc..(Wilks, David) |
| Filing 9 MOTION for an Expedited Teleconference to Resolve Discovery Dispute - filed by Regeneron Pharmaceuticals, Inc.. Motions referred to Laura D. Hatcher.(Wilks, David) |
|
Filing 8
ORAL ORDER REFERRING CASE to Magistrate Judge Laura D Hatcher - IT IS HEREBY ORDERED that this case and the pending motion are referred to Magistrate Judge Laura D. Hatcher to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine or the pre-trial conference), subject to 28 U.S.C. 636(b) and any further Order of the Court. All subsequent filings in this action shall be captioned as follows: Civil Action No. 23-1124-MN-LDH. ORDERED by Judge Maryellen Noreika on 10/16/2023. Motions referred to Laura D Hatcher.(dlw)
|
| Pro Hac Vice Attorneys Zachary N Ferguson,Irena Royzman, and Jennifer S Windom for Regeneron Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Christine Willgoos for Regeneron Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
|
SO ORDERED re #7 MOTION for Pro Hac Vice Appearance of Attorney Jennifer S. Windom, Christine Willgoos, Irena Royzman and Zachary N. Ferguson filed by Regeneron Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 10/12/2023. (dlw)
|
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Jennifer S. Windom, Christine Willgoos, Irena Royzman and Zachary N. Ferguson - filed by Regeneron Pharmaceuticals, Inc.. (Wilks, David) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Regeneron Pharmaceuticals, Inc. (smg) |
| Filing 5 DECLARATION of Duck Soon Chang in Support of D.I. #1 Ex Parte APPLICATION for an Order Pursuant to 28 U.S.C. 1782 to Take Discovery for Use in Foreign Proceedings by Regeneron Pharmaceuticals, Inc. (Attachments: #1 Exhibit 1-12)(smg) |
| Filing 4 DECLARATION of Seong-Soo Park in Support of D.I. #1 Ex Parte APPLICATION for an Order Pursuant to 28 U.S.C. 1782 to Take Discovery for Use in Foreign Proceedings by Regeneron Pharmaceuticals, Inc. (smg) |
| Filing 3 MEMORANDUM of Law in Support of D.I. #1 Ex Parte APPLICATION for an Order Pursuant to 28 U.S.C. 1782 to Take Discovery for Use in Foreign Proceedings. Answering Brief/Response due date per Local Rules is 10/24/2023. (smg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Filing 1 Ex Parte APPLICATION for an Order Pursuant to 28 U.S.C. 1782 to Take Discovery for Use in Foreign Proceedings (Filing fee $ 402, receipt number ADEDC-4243535) - filed by Regeneron Pharmaceuticals, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Text of Proposed Order, #4 Civil Cover Sheet)(smg) |
| No Summons Issued. (smg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: In re: Request from South Korea | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Petitioner: Regeneron Pharmaceuticals, Inc. | |
| Represented By: | David E. Wilks |
| Represented By: | Irena Royzman |
| Represented By: | Jennifer S Windom |
| Represented By: | Zachary N Ferguson |
| Represented By: | Christine Willgoos |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Respondent: Biogen Inc. | |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
